Report cover image

Respiratory Assist Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

Publisher GlobalData
Published Jun 30, 2023
Length 75 Pages
SKU # GBDT18089814

Description

Respiratory Assist Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update


Summary

GlobalData's Medical Devices sector report, “Respiratory Assist Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Respiratory Assist Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Respiratory Assist Devices facilitate breathing during respiratory failure and other respiratory disease conditions.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Respiratory Assist Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Respiratory Assist Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Respiratory Assist Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

75 Pages
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Respiratory Assist Devices Overview
4 Products under Development
4.1 Respiratory Assist Devices - Pipeline Products by Stage of Development
4.2 Respiratory Assist Devices - Pipeline Products by Segment
4.3 Respiratory Assist Devices - Pipeline Products by Territory
4.4 Respiratory Assist Devices - Pipeline Products by Regulatory Path
4.5 Respiratory Assist Devices - Pipeline Products by Estimated Approval Date
4.6 Respiratory Assist Devices - Ongoing Clinical Trials
5 Respiratory Assist Devices - Pipeline Products under Development by Companies
5.1 Respiratory Assist Devices Companies - Pipeline Products by Stage of Development
5.2 Respiratory Assist Devices – Companies Pipeline Products by Stage of Development
6 Respiratory Assist Devices Companies and Product Overview
6.1 Advanced Respiratory Technologies LLC Company Overview
6.1.1 Advanced Respiratory Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
6.2 ALung Technologies Inc Company Overview
6.2.1 ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
6.3 Baxter Healthcare Corp Company Overview
6.3.1 Baxter Healthcare Corp Pipeline Products & Ongoing Clinical Trials Overview
6.4 Belluscura Plc Company Overview
6.4.1 Belluscura Plc Pipeline Products & Ongoing Clinical Trials Overview
6.5 Braile Biomedica Ltda Company Overview
6.5.1 Braile Biomedica Ltda Pipeline Products & Ongoing Clinical Trials Overview
6.6 Breethe, Inc. Company Overview
6.6.1 Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.7 Case Western Reserve University Company Overview
6.7.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview
6.8 Collplant Biotechnologies Ltd Company Overview
6.8.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.9 enmodes GmbH Company Overview
6.9.1 enmodes GmbH Pipeline Products & Ongoing Clinical Trials Overview
6.10 Liberate Medical LLC Company Overview
6.10.1 Liberate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
6.11 Lung Biotechnology PBC Company Overview
6.11.1 Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview
6.12 MAQUET Cardiopulmonary AG Company Overview
6.12.1 MAQUET Cardiopulmonary AG Pipeline Products & Ongoing Clinical Trials Overview
6.13 MC3 Inc Company Overview
6.13.1 MC3 Inc Pipeline Products & Ongoing Clinical Trials Overview
6.14 McGowan Institute for Regenerative Medicine Company Overview
6.14.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview
6.15 Minnesota Health Solutions Corporation Company Overview
6.15.1 Minnesota Health Solutions Corporation Pipeline Products & Ongoing Clinical Trials Overview
6.16 Miromatrix Medical Inc Company Overview
6.16.1 Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.17 Postgraduate Institute of Medical Education and Research Company Overview
6.17.1 Postgraduate Institute of Medical Education and Research Pipeline Products & Ongoing Clinical Trials Overview
6.18 Rice University Company Overview
6.18.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview
6.19 The Charles Stark Draper Laboratory Inc Company Overview
6.19.1 The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview
6.20 TVS Group Company Overview
6.20.1 TVS Group Pipeline Products & Ongoing Clinical Trials Overview
6.21 U.S. Ann Arbor Healthcare System Company Overview
6.21.1 U.S. Ann Arbor Healthcare System Pipeline Products & Ongoing Clinical Trials Overview
6.22 University of Arizona Company Overview
6.22.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
6.23 University of California Los Angeles Company Overview
6.23.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
6.24 University of Michigan Company Overview
6.24.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
6.25 University of Pittsburgh Company Overview
6.25.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
6.26 Veterans Health Administration Company Overview
6.26.1 Veterans Health Administration Pipeline Products & Ongoing Clinical Trials Overview
6.27 X-COR Therapeutics Company Overview
6.27.1 X-COR Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
6.28 Xenios AG Company Overview
6.28.1 Xenios AG Pipeline Products & Ongoing Clinical Trials Overview
7 Respiratory Assist Devices- Recent Developments
7.1 May 30, 2023: Miromatrix presenting at the 2023 American Transplant Congress
7.2 May 09, 2023: Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
7.3 May 04, 2023: Teleflex reports first quarter financial results and full year 2023 outlook
7.4 Apr 20, 2023: Teleflex announces first quarter 2023 earnings conference call information
7.5 Apr 10, 2023: Draper Names Sarah Leeper Vice President and General Manager for Electronic Systems
7.6 Mar 08, 2023: UCSF Health Appoints Two Prominent Healthcare Executives to Senior Leadership Positions
7.7 Feb 23, 2023: Teleflex Reports Fourth Quarter and Full Year 2022 Financial Results
7.8 Feb 21, 2023: Teleflex to Present at the 44th Annual Raymond James Institutional Investors Conference
7.9 Feb 09, 2023: Teleflex Announces Fourth Quarter 2022 Earnings Conference Call Information
7.10 Jan 10, 2023: Inogen Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Within Company Expectations
7.11 Nov 09, 2022: Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
7.12 Oct 27, 2022: Teleflex Reports Third Quarter Financial Results And Full Year Outlook
7.13 Oct 13, 2022: Teleflex Announces Third Quarter 2022 Earnings Conference Call Information
7.14 Oct 05, 2022: Inogen to Announce Third Quarter 2022 Financial Results on November 2, 2022
7.15 Sep 26, 2022: Miromatrix CEO Jeff Ross to Present at the Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event
7.16 Sep 20, 2022: Miromatrix CEO Jeff Ross to Present at the Bioregate European Regenerative Medicine Forum
7.17 Aug 15, 2022: Miromatrix Reports Second Quarter 2022 Results and Provides Corporate Update
7.18 Aug 10, 2022: Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results
7.19 Aug 01, 2022: Miromatrix to Report Second Quarter 2022 Financial Results
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Respiratory Assist Devices - Pipeline Products by Stage of Development
Table 2: Respiratory Assist Devices - Pipeline Products by Segment
Table 3: Respiratory Assist Devices - Pipeline Products by Territory
Table 4: Respiratory Assist Devices - Pipeline Products by Regulatory Path
Table 5: Respiratory Assist Devices - Pipeline Products by Estimated Approval Date
Table 6: Respiratory Assist Devices - Ongoing Clinical Trials
Table 7: Respiratory Assist Devices Companies - Pipeline Products by Stage of Development
Table 8: Respiratory Assist Devices – Companies Pipeline Products by Stage of Development
Table 9: Advanced Respiratory Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Pulmonary Assist Device - Product Status
Table 11: Pulmonary Assist Device - Product Description
Table 12: ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Hattler Catheter - Product Status
Table 14: Hattler Catheter - Product Description
Table 15: Next Generation Artificial Lung - Product Status
Table 16: Next Generation Artificial Lung - Product Description
Table 17: ULFED -<1L/min - Product Status
Table 18: ULFED -<1L/min - Product Description
Table 19: ULFED - 250 mL/min - Product Status
Table 20: ULFED - 250 mL/min - Product Description
Table 21: Baxter Healthcare Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 22: PrismaLung+ - Product Status
Table 23: PrismaLung+ - Product Description
Table 24: Baxter Healthcare Corp - Ongoing Clinical Trials Overview
Table 25: PrismaLung+ - A Novel ECCO2R Device as a Lung Protective Measure in Hypercapnic Respiratory Failure: A Prospective Multicenter Trial
Table 26: PrismaLung+ - A Post-market Study of Performance and Safety of Low-flow Extracorporeal Carbon Dioxide Removal Using PrismaLung+ in Patients with Mild to Moderate Acute Respiratory Distress Syndrome
Table 27: Belluscura Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Portable Artificial Lung - Product Status(Belluscura Plc)
Table 29: Portable Artificial Lung - Product Description(Belluscura Plc)
Table 30: Braile Biomedica Ltda Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Artificial Respirator - Product Status
Table 32: Artificial Respirator - Product Description
Table 33: Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Abiomed Breethe OXY-1 System - Product Status
Table 35: Abiomed Breethe OXY-1 System - Product Description
Table 36: Breethe, Inc. - Ongoing Clinical Trials Overview
Table 37: Abiomed Breethe OXY-1 System - Breethe Abiomed Recovery Registry (BART)
Table 38: Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Portable Artificial Lung - Product Status(Case Western Reserve University)
Table 40: Portable Artificial Lung - Product Description(Case Western Reserve University)
Table 41: Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 42: 3D Bioprinted Lung Transplant - Product Status
Table 43: 3D Bioprinted Lung Transplant - Product Description
Table 44: enmodes GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 45: RAS-Q - Product Status
Table 46: RAS-Q - Product Description
Table 47: Liberate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 48: SecondBreath - Product Status
Table 49: SecondBreath - Product Description
Table 50: Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview
Table 51: XenoLung - Product Status
Table 52: XenoLung - Product Description
Table 53: MAQUET Cardiopulmonary AG Pipeline Products & Ongoing Clinical Trials Overview
Table 54: PALP - Product Status
Table 55: PALP - Product Description
Table 56: MC3 Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 57: BioLung - Product Status
Table 58: BioLung - Product Description
Table 59: McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview
Table 60: A - modELAS - Product Status
Table 61: A - modELAS - Product Description
Table 62: A,P- modELAS - Product Status
Table 63: A,P- modELAS - Product Description
Table 64: Biohybrid Artificial Lung - Product Status
Table 65: Biohybrid Artificial Lung - Product Description
Table 66: Chronic Artificial Lung - Product Status
Table 67: Chronic Artificial Lung - Product Description
Table 68: Impeller Percutaneous Respiratory Assist Catheter (iPRAC) - Product Status
Table 69: Impeller Percutaneous Respiratory Assist Catheter (iPRAC) - Product Description
Table 70: P-modelas - Product Status
Table 71: P-modelas - Product Description
Table 72: Minnesota Health Solutions Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 73: Non-Invasive Ventilator Respiratory Interface - Product Status
Table 74: Non-Invasive Ventilator Respiratory Interface - Product Description
Table 75: Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 76: Mirolung - Product Status
Table 77: Mirolung - Product Description
Table 78: Postgraduate Institute of Medical Education and Research Pipeline Products & Ongoing Clinical Trials Overview
Table 79: SMARTS - COVID-19 - Product Status
Table 80: SMARTS - COVID-19 - Product Description
Table 81: Rice University Pipeline Products & Ongoing Clinical Trials Overview
Table 82: Respiratory Assist Device - Product Status
Table 83: Respiratory Assist Device - Product Description
Table 84: The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 85: Silicone-Based Microfluidic Artificial Lung - Product Status
Table 86: Silicone-Based Microfluidic Artificial Lung - Product Description
Table 87: TVS Group Pipeline Products & Ongoing Clinical Trials Overview
Table 88: Sundaram Ventago - Product Status
Table 89: Sundaram Ventago - Product Description
Table 90: U.S. Ann Arbor Healthcare System Pipeline Products & Ongoing Clinical Trials Overview
Table 91: 3D-Printed Artificial Lung - Product Status
Table 92: 3D-Printed Artificial Lung - Product Description
Table 93: University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
Table 94: HeCOS - Product Status
Table 95: HeCOS - Product Description
Table 96: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
Table 97: Percutaneous Catheter for Lung Assist Device - Product Status
Table 98: Percutaneous Catheter for Lung Assist Device - Product Description
Table 99: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
Table 100: M-Lung - Product Status
Table 101: M-Lung - Product Description
Table 102: University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
Table 103: P-PAL - Product Status
Table 104: P-PAL - Product Description
Table 105: Paracorporeal Ambulatory Assist Lung - Product Status
Table 106: Paracorporeal Ambulatory Assist Lung - Product Description
Table 107: Veterans Health Administration Pipeline Products & Ongoing Clinical Trials Overview
Table 108: 3D Printed Microfluidic Artificial Lung - Product Status
Table 109: 3D Printed Microfluidic Artificial Lung - Product Description
Table 110: Artificial Lung - Product Status
Table 111: Artificial Lung - Product Description
Table 112: X-COR Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
Table 113: Extracorporeal CO2 Removal Device - Product Status
Table 114: Extracorporeal CO2 Removal Device - Product Description
Table 115: Xenios AG Pipeline Products & Ongoing Clinical Trials Overview
Table 116: i-lung - Product Status
Table 117: i-lung - Product Description
Table 118: Glossary
2.2 List of Figures
Figure 1: Respiratory Assist Devices - Pipeline Products by Stage of Development
Figure 2: Respiratory Assist Devices - Pipeline Products by Segment
Figure 3: Respiratory Assist Devices - Pipeline Products by Territory
Figure 4: Respiratory Assist Devices - Pipeline Products by Regulatory Path
Figure 5: Respiratory Assist Devices - Pipeline Products by Estimated Approval Date
Figure 6: Respiratory Assist Devices - Ongoing Clinical Trials

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us